Citation: | WANG Shuai, Javed Akhtar, WANG Zhou. stathmin Silencing Increases Sensitivity of Esophageal Squamous Cell Carcinoma Cells to Paclitaxel[J]. Cancer Research on Prevention and Treatment, 2015, 42(02): 126-129. DOI: 10.3971/j.issn.1000-8578.2015.02.006 |
[1] |
Jemal A, Bray F, Center MM, et al. Global cancer statistics[J]. CA Cancer J Clin, 2011, 61(2): 69-90.
|
[2] |
Wang S, Wang Z. Review on RUNX3 gene and esophageal cancer[J]. Zhonghua Zhong Liu Fang Zhi Za Zhi, 2012, 19(23):1831-5. [王 帅, 王洲. RUNX3基因与食管癌相关性的研究进展[J]. 中华肿 瘤防治杂志, 2012, 19(23):1831-5.]
|
[3] |
Overman MJ, Kazmi SM, Jhamb J, et al. Weekly docetaxel, cisplatin, and 5-fluorouracil as initial therapy for patients with advanced gastric and esophageal cancer[J]. Cancer, 2010, 11 6(6):1446-53.
|
[4] |
Pang X, Li SL, Zhao ZH, et al. Clinical significance of expression of TGF-β1,TIEG1 and stathmin proteins in esophageal squamous cell carcinoma[J]. Shi Jie Hua Ren Xiao Hua Za Zhi, 2013, 21(4): 32 7-31. [庞霞, 李晟磊, 赵志华, 等. TGF-β1、TIEG1和Stathmin 蛋白在食管鳞状细胞癌组织中的表达及临床意义[J]. 世界华人 消化杂志, 2013, 21(4): 327-31.]
|
[5] |
Wang F, Wang LX, He W, et al. Expression of stathmin in esophageal squamous cell carcinoma and its biological significance[J]. Nanfang Yi Ke Da Xue Xue Bao, 2010,30(7): 15 52-7.[王峰, 王留兴, 何伟, 等. Stathmin基因在食管鳞癌中的 表达及生物学意义[J]. 南方医科大学学报, 2010, 30(7): 1552-7.]
|
[6] |
Xiao YJ, Wang HM, Han ZX, et al. Reverse paclitaxel resistance by silencing stathmin and mdr1 in ovarian cancer cells[J]. Zhong Liu Fang Zhi Yan Jiu,2011, 38(3):243-6. [肖玉洁, 王红梅, 韩正 祥, 等. 靶向stathmin和mdr1基因逆转卵巢癌细胞紫杉醇耐药的 研究[J] 肿瘤防治研究, 2011, 38(3): 243-6.]
|
[7] |
Zhang HZ, Wang Y, Gao P, et al. Silencing stathmin gene expression by survivin promoter-driven siRNA vector to reverse malignant phenotype of tumor cells[J]. Cancer Biol Ther, 2006, 5( 11): 1457-61.
|
[8] |
Gao D, Hu J, Zhang X, et al. Effect of hOGG1 over-expression on cisplatin resistance in esophageal squamous carcinoma cells[J]. Cancer Biother Radiopharm, 2013, 28(6): 433-40.
|
[9] |
Balachandran R, Welsh MJ, Day BW. Altered levels and regulation of stathmin in paclitaxel-resistant ovarian cancer cells[J]. Oncogene, 2003, 22(55): 8924-30.
|
[10] |
Wang R, Dong K, Lin F, et al. Inhibiting proliferation and enhancing chemosensitivity to taxanes in osteosarcoma cells by RNA interference-mediated downregulation of stathmin expression[J]. Mol Med, 2007, 13(11-12): 567-75.
|
[11] |
Nishio K, Nakamura T, Koh Y, et al. Oncoprotein 18 overexpression increases the sensitivity to vindesine in the human lung carcinoma cells[J]. Cancer, 2001, 91(8): 1494-9.
|